Color cases should be printed in color to maximize their performance. In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was analyzing the initiation health care business's 2014 marketing plan.
On December 31st, 2013 Vaxess had obtained an exclusive permit to a succession of patents to get a silk protein technology that, when added to vaccines, reduced or removed the requirement for refrigeration between the production and delivery to the end patient.
Schrader and his coworkers needed to determine which vaccines to focus and whether and just how to target the drug companies that manufactured the vaccines or the quasi-government organizations (for example UNICEF and PAHO) and nongovernment organizations (like GAVI) that purchased substantial amounts of vaccines for the developing world.
Vaxess Technologies, Inc. Case Study Solution
PUBLICATION DATE: May 02, 2014 PRODUCT #: 514107-PDF-ENG
This is just an excerpt. This case is about SALES & MARKETING
Related Case Solutions & Analyses:
An NHLRidefilm Attraction
Intuit QuickBooks
ServerVault: Reliable Secure and Wicked Fast (V. 1.5)
Hilton HHonors Worldwide: Loyalty Wars
The Tata Nano: The People’s Car (Abridged)
Competition Simulator Exercise: Questions
HCL Beanstalk: All-in-One Desktop Re-Launch
Emerging Markets: Look Before You Leap
Carslberg In Emerging Market
Obama versus Clinton: The YouTube Primary
